13F-HR filed by Prosight Management, LP
Prosight Management, LP filed this 13F-HR for the quarter ended 2024-12-31, filed 2025-02-14, with 36 holding rows worth $361,837,867.
- Accession
- 0001420506-25-000459
- Filer
- CIK 1617201
- Filed
- 2025-02-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2024
A holdings report, 36 entries on the cover page, a total value of $361,837,867 stated on the cover page (in dollars after the unit check, H1), rows summing to $361,837,867 with VALUE read as dollars as filed, 13F file number 028-18450. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| LAKEFRONT BIOTHERAPEUTICS NV | 36315X101 | SPON ADR | 1,025,000 | $28,187,500 | dollars as filed | |
| ACADIA HEALTHCARE COMPANY INC COM | 00404A109 | Stock | 692,000 | $27,437,800 | dollars as filed | |
| BRIDGEBIO PHARMA INC | 10806X102 | COM | 995,000 | $27,302,800 | dollars as filed | |
| MEIRAGTX HOLDINGS PLC | G59665102 | COMMON STOCK | 4,390,837 | $26,740,197 | dollars as filed | |
| ABCELLERA BIOLOGICS INC COM | 00288U106 | Stock | 7,350,000 | $21,535,500 | dollars as filed | |
| ADC THERAPEUTICS SA | H0036K147 | COMMON STOCK | 9,515,000 | $18,934,850 | dollars as filed | |
| MIRUM PHARMACEUTICALS INC | 604749101 | COM | 451,127 | $18,654,101 | dollars as filed | |
| ICON PUB LTD CO SHS | G4705A100 | Stock | 85,000 | $17,825,350 | dollars as filed | |
| ROIVANT SCIENCES LTD | G76279101 | SHS | 1,500,000 | $17,745,000 | dollars as filed | |
| JANUX THERAPEUTICS INC | 47103J105 | COM | 329,768 | $17,655,779 | dollars as filed | |
| SCHRODINGER INC COM | 80810D103 | Stock | 720,500 | $13,898,445 | dollars as filed | |
| ROCKET PHARMACEUTICALS INC | 77313F106 | COM | 1,088,706 | $13,685,034 | dollars as filed | |
| ZYMEWORKS INC | 98985Y108 | COM | 820,000 | $12,004,800 | dollars as filed | |
| KURA ONCOLOGY INC COM | 50127T109 | Stock | 1,325,000 | $11,540,750 | dollars as filed | |
| AMICUS THERAPEUTICS INC | 03152W109 | COM | 920,000 | $8,666,400 | dollars as filed | |
| ZIMMER BIOMET HOLDINGS INC COM | 98956P102 | Stock | 80,000 | $8,450,400 | dollars as filed | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 620,000 | $8,196,400 | dollars as filed | |
| SHATTUCK LABS INC | 82024L103 | COMMON STOCK | 6,638,935 | $8,033,111 | dollars as filed | |
| IMMUNOVANT INC | 45258J102 | COM | 305,523 | $7,567,805 | dollars as filed | |
| BLUEPRINT MEDICINES CORP | 09627Y109 | COM | 67,000 | $5,843,740 | dollars as filed | |
| PROTHENA CORP PLC SHS | G72800108 | Stock | 418,122 | $5,790,990 | dollars as filed | |
| GALAPAGOS NV | 36315X901 | SPON ADR | 176,900 | $4,864,750 | dollars as filed | call |
| CYTOMX THERAPEUTICS INC | 23284F105 | COMMON STOCK | 3,905,000 | $4,022,150 | dollars as filed | |
| HAEMONETICS CORP MASS COM | 405024100 | Stock | 46,700 | $3,646,336 | dollars as filed | |
| CENTENE CORP DEL COM | 15135B101 | Stock | 55,000 | $3,331,900 | dollars as filed | |
| SIGHT SCIENCES INC | 82657M105 | COMMON STOCK | 908,847 | $3,308,203 | dollars as filed | |
| LIVANOVA PLC | G5509L101 | SHS | 70,000 | $3,241,700 | dollars as filed | |
| CORBUS PHARMACEUTICALS | 21833P301 | COM NEW | 270,000 | $3,186,000 | dollars as filed | |
| ERASCA INC COM | 29479A108 | Stock | 947,110 | $2,377,246 | dollars as filed | |
| SPYRE THERAPEUTICS INC | 00773J202 | COM NEW | 80,000 | $1,862,400 | dollars as filed | |
| CAREDX INC | 14167L103 | COM | 80,000 | $1,712,800 | dollars as filed | |
| MURAL ONCOLOGY PUB LTD CO | G63365103 | ORD SHS | 466,822 | $1,503,167 | dollars as filed | |
| FORTREA HLDGS INC COMMON STOCK | 34965K107 | Stock | 55,100 | $1,027,615 | dollars as filed | |
| REIN THERAPEUTICS INC | 00887A204 | COM NEW | 404,979 | $931,452 | dollars as filed | |
| IMMUNOME INC | 45257U108 | COM | 54,342 | $577,112 | dollars as filed | |
| ONKURE THERAPEUTICS INC | 68277Q105 | COM CL A | 63,754 | $548,284 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001420506-25-000459 | this filing | 2025-02-14 | acceptance time not in the bulk data set |